Skip to main content
Premium Trial:

Request an Annual Quote

Lacks Honored by WHO

Henrietta Lacks, whose cancer cells were taken without her knowledge and fueled decades of biomedical research, has received a posthumous award from the World Health Organization for her contributions to science, according to the Associated Press.

"Henrietta Lacks was exploited. She is one of many women of color whose bodies have been misused by science," Tedros Adhanom Ghebreyesus, the WHO director-general, said in a ceremony honoring Lacks, according to the AP. "She placed her trust in the health system so she could receive treatment. But the system took something from her without her knowledge or consent."

As the New York Times notes, Tedros added that the inequality has continued, as HeLa cells have been used, for instance, to develop cervical cancer and COVID-19 vaccines that are not available to poorer nations. Groesbeck Parham, the chair of a WHO group on eliminating cervical cancer, said that the best way to honor Lacks' contribution to science would be to address inequities in science and medicine, the Times adds.

Last week, members of the Lacks family filed a lawsuit against Thermo Fisher Scientific for mass-producing and selling HeLa cells, and a lawyer for the Lacks family has said other companies may also be sued.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.